SUMMARY Seven cases of diffuse interstitial lung disease (DILD) are reported with an unequivocal temporal relationship between the development of the lung disease and treatment with gold (6 cases) and penicillamine (1 case). They were characterised clinically by the sudden onset of dyspnoea and crepitations and radiologically by diffuse bilateral pulmonary shadowing. Most showed evidence of hypersensitivity such as eosinophilia, a raised serum IgE level in response to gold, proteinuria, thrombocytopenia, or an immediate postinjection reaction. DILD is a serious complication of treatment with gold and penicillamine that is commoner than generally realised.
Diffuse interstitial lung disease (DILD) may occur in association with rheumatoid arthritis (RA). In one series of 516 patients with RA 1-6% also had DILD.1 In 1976 Geddes and Brostoff2 and Winterbauer et al. 3 both reported a possible relationship between DILD and gold therapy. Since then a number of reports have described DILD developing during gold therapy.4" '2 Other reports have described a similar relationship to treatment with penicillamine. [13] [14] [15] [16] We report a further 7 patients who developed DILD during treatment with gold or penicillamine. In all cases there was an unequivocal temporal relationship between the development of DILD and treatment with these drugs. To identify the nature and extent of this clinical problem we have reviewed all the cases where this adverse reaction had been described. manifestations. A chest x-ray was normal, and she had no respiratory symptoms or signs. Gold was started.
After 6 intramuscular injections of 50 mg sodium aurothiomalate she had an immediate postinjection reaction consisting of coldness and shivering. After 6 hours she developed a wheeze. Similar reactions occurred with the seventh and eighth injections, and she became increasingly dyspnoeic on exercise. Gold was discontinued. The severity of the dyspnoea increased over the next month, and she was found to have fine crepitation in both lung fields. A chest x-ray showed diffuse interstitial shadowing (Fig. 1) . Respiratory function tests indicated a restrictive defect, and the vital capacity was 2-04 1. (1-89 standard deviations below the predicted value). The transfer factor for carbon monoxide was 3 6 mmol/ min/kPa (3.20 standard deviations below the predicted value). An eosinophil count was 450 x 106/1. Immunoglobulin estimation showed a raised IgA at 9-0 g/l (reference range 0-8-4-5 g/l) with normal IgG and IgM levels. C3 A chest x-ray showed widespread interstitial shadowing in both lower zones in addition to the apical changes. He developed proteinuria, and gold was stopped. A single further gold injection 6 months later caused severe thrombocytopenia.
Over the next 6 years he continued to have marked dyspnoea. His chest radiograph showed diffuse fibrosis (Fig. 2) . Lung function tests showed a restrictive defect with a reduced vital capacity of 2 04 1 (2-90 standard deviations below predicted value) and a reduced transfer factor of2*0 mmol/min/ kPa (2@92 standard deviation below the predicted value).
CASE 6
A woman presented in 1976 aged 50 years. She had an 8-year history of RA involving PIP, MCP, wrist, and MTP joints. There were subcutaneous nodules but no other extra-articular features. Her haemoglobin was 10-5 g/dl, ESR 38 mm/h, and RoseWaaler titre 1:64. She had no symptoms or signs of respiratory disease, and her chest x-ray was normal. An eosinophil count was 405 x 106/1.
Gold was started. After 7 intramuscular injections of 50 mg sodium aurothiomalate she developed an eosinophilia; the eosinophil count was 1170 x 106/1.
Further injections of gold were not given, but that same week she developed dyspnoea, and over the next 4 weeks the exertional dyspnoea increased in severity until she was breathless at rest. She had bilaterial crepitations. A chest x-ray showed bilateral diffuse interstitial shadowing. A lung biopsy showed an inflammatory infiltrate with many polymorphonuclear leucocytes, fibrin deposition, and the development of fibrosis (Figs 3 and 4) . She showing the presence of collagen fibres (arrowed). These were blue in the original. gold,25 and in these it may have contributed to the development of the pulmonary disease. The pathological evidence for a relationship between pleural disease and necrobiotic nodules and RA is undisputed, but in DILD the pathological relationship is less certain. 26 We conclude that DILD as a serious adverse reaction to gold and penicillamine is commoner than generally realised. The incidence of this adverse reaction can be satisfactorily determined only by a prospective study, and we suggest this merits serious consideration, possibly on a multicentre basis. Dyspnoea developing during gold or penicillamine therapy requires careful evaluation, and if there is any suggestion of DILD these drugs should be stopped, since some patients show evidence of regression of the lung changes with cessation of therapy. 
